SAMJIN PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19,800 KRW | +0.05% |
|
-0.50% | -8.33% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2021 | 250B 186M | Sales 2022 | 274B 204M | Capitalization | 344B 256M |
|---|---|---|---|---|---|
| Net income 2021 | 28.4B 21.1M | Net income 2022 | 21.89B 16.27M | EV / Sales 2021 | 1.48 x |
| Net Debt 2021 | 42.79B 31.8M | Net Debt 2022 | 82.85B 61.56M | EV / Sales 2022 | 1.56 x |
| P/E ratio 2021 |
11.4
x | P/E ratio 2022 |
14.8
x | Employees | 586 |
| Yield 2021 |
3.04% | Yield 2022 |
3.12% | Free-Float | 45.28% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.05% | ||
| 1 week | -0.50% | ||
| 1 month | -0.60% | ||
| 3 months | -4.35% | ||
| 6 months | -12.39% | ||
| Current year | -8.33% |
1 week
19 710.00
19 930.00
1 month
19 370.0019 950.00
Current year
19 370.0021 850.00
1 year
19 370.0025 000.00
3 years
19 370.0030 500.00
5 years
15 900.0036 800.00
10 years
15 900.0064 900.00
| Managers | Title | Age | Since |
|---|---|---|---|
Yong-Ju Choi
CEO | Chief Executive Officer | 67 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Eui-Hwan Cho
CHM | Chairman | 82 | - |
Seung-Ju Choi
CHM | Chairman | 82 | - |
Yong-Ju Choi
CEO | Chief Executive Officer | 67 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 19,800 | +0.05% | 12,530 |
| 24-05-14 | 19,790 | -0.10% | 12,203 |
| 24-05-13 | 19,810 | -0.10% | 24,621 |
| 24-05-10 | 19,830 | 0.00% | 8,333 |
| 24-05-09 | 19,830 | -0.35% | 8,692 |
End-of-day quote Korea S.E., May 15, 2024
More quotes
Samjin Pharmaceuticals co., LTD. is a Korea-based company mainly engaged in the manufacture of pharmaceutical products. The Companyâs products include antipyretics, analgesics, antiphlogistic agents, osteoarthritis agents, osteopathic agents, antihistaminic agents, circulatory system drugs, gastrointestinal agents, osteoporosis treatments, hepatic disease agents, respiratory agents, antibiotics agents, detoxifying agents, antifungal agents, antineoplastic agents and others. Its products are provided in the forms of tablets, injections, capsules and others. It distributes its products to the hospitals and drugstores. The Company supplies its products within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -8.33% | 187M | |
| +21.98% | 43.92B | |
| +23.03% | 23.09B | |
| +19.25% | 15.35B | |
| +14.03% | 13.61B | |
| +46.40% | 12.02B | |
| -10.49% | 7B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +13.88% | 5.6B |
- Stock Market
- Equities
- A005500 Stock
